SIVIK GLOBAL Overview

Sivik Global Healthcare Llc is a hedge fund that manages 281.8 MM dollars in regulatory AUM and has 3 employees, of which 2 perform investment advisory functions.

The manager's has disclosed holdings from 12/31/01 to 09/30/16. The fund's latest filing disclosed 198MM in positions, representing 70% of the manager's regulatory AUM.

SIVIK GLOBAL StockAlpha

-0%
Top 25%
3yr StockAlpha Register for more...

Fundamental & Technical Factor Exposure

Market Cap Beta Volatility
Momentum (12M) Momentum (6M) Momentum (3M)
Price/Book Price/Earnings Price/Cash Flow
Dividend Yield Sales Growth Earnings Growth
ROE ROA ROC
EBIDTA Margin Debt/Assets Hedge Fund Crowding

SIVIK GLOBAL Since Last Filing Return Details

Ticker Size Sector Stock Move StockAlpha Attribution Days to Liquidate Trade Crowdedness
LLY 4.06% Health -14.97% -0.41% 0 22%
ZBH 3.94% Health -19.54% -0.59% 0 13%
Unlock Positions and Returns Details
FEATURED IN
Logo of CNBC
Wall Street Journal Logo
Pensions & Investments logo
BloomBerg Logo

SIVIK GLOBAL Founders and Key Employees

Name Title In Position Since
Krishen K. Sud Managing Member & Chief Compliance Officer July-2013

SIVIK GLOBAL Brokers, Custodians, Auditors and Administrators

Type Company
Administrator Pro
Administrator Pro
Auditor Pro
Custodian Pro
Prime Broker Pro

SIVIK GLOBAL Investment Strategy

Methods of Analysis, Investment Strategies and Risk of Loss

The Sivik Funds investment strategies are rooted in a rigorous bottom up research process which is designed to identify mispriced securities in the healthcare sector with a focus on investment ideas with an investment horizon of 6-18 months. As part of the investment process, Sivik meets with the management of various companies, speaks with physicians, hires consultants, as well as attends various medical and regulatory meetings. In addition to leveraging proprietary research capabilities, expertise and an extensive information network designed to identify less-crowded opportunities the investment manager utilizes active risk management focused on diversification, market exposure, and liquidity. The investment manager will limit exposure to any individual stock to 7% and limit aggregate exposure to biotechnology to 25% of the net asset value of the portfolio. In order to generate incremental returns, Sivik will tra...
Unlock Full Investment Process Description

SIVIK GLOBAL Portfolio Concentration

SIVIK GLOBAL Location

380 GREENWICH AVE
2ND FLOOR
GREENWICH, Connecticut
UNITED STATES, 06830

SIVIK GLOBAL Contact Information

Phone Number: 203-769-8600
Fax Number: 203-971-3720
Website:

READ RECENT SYMMETRIC REPORTS

Disclaimer

The information contained herein: (1) is proprietary to Symmetric and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Symmetric nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance and skill metrics are no guarantee of future results. "Symmetric," "Symmetric.io" and the Symmetric logo are marks of Symmetric, Inc. Read our privacy policy here. Read our terms of use here
Path A